J Frontier Co

J Frontier Co Financial Leverage

The Financial Leverage (Equity Multiplier) of J Frontier Co (2934.T) as of Oct 17, 2026 is 7.80. In the previous year, Financial Leverage (Equity Multiplier) was 6.52 — a change of 19.61% (higher).

Financial Leverage

7.80

YoY

19.61%

Last updated:

Financial Leverage (Equity Multiplier) of J Frontier Co is 2026 7.80 . Financial Leverage (Equity Multiplier) of J Frontier Co was 2025 6.52 . It decreases by 19.61% higher compared to the previous year.

The J Frontier Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
2.56 JPY
Jan 1, 2020
2.41 JPY
Jan 1, 2021
2.05 JPY
Jan 1, 2022
1.48 JPY
Jan 1, 2023
2.93 JPY
Jan 1, 2024
10.01 JPY
Jan 1, 2025
6.52 JPY
Jan 1, 2026
7.80 JPY
The J Frontier Co Financial Leverage history
YEARFinancial LeverageYoY
7.80+19.61%
6.52-34.87%
10.01+242.04%
2.93+98.42%
1.48-27.90%
2.05-15.14%
2.41-5.83%
2.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

J Frontier Co Stock analysis

What does J Frontier Co do? J Frontier Co Ltd, listed on the Tokyo Stock Exchange under ticker 2934.T, is a healthcare company headquartered in Shibuya-Ku, Tokyo. The company went public on August 27, 2021, and currently employs 255 full-time staff. J Frontier operates through three business segments focused on healthcare products and services. The Healthcare Sales segment handles the planning, development, and distribution of health foods and cosmetics, including the 328 selection series of fermented hydrogen products, alongside mail-order sales. The Medical Care Sales segment manages dispensing pharmacies, mail-order sales of ethical drugs, and the development and distribution of pharmaceuticals such as the Why Pure series and Chinese herbs. The Health Care Marketing segment provides advertising services, sales promotion support, and wholesale of in-house products for healthcare-related businesses. The company’s website is https://jfrontier.jp/. J Frontier does not disclose specific financial figures or details about its founding year, key executives, or acquisition history beyond the publicly available information. It is categorized under the Health Care sector and Industry in financial databases. The company’s operations are based in Shibuya-Ku, Tokyo, and it serves customers through both direct sales and online channels. No additional product names, historical milestones, or personnel details are provided in the available data. J Frontier Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about J Frontier Co stock

Financial Leverage (Equity Multiplier) of J Frontier Co is 7.80 in 2026.

Financial Leverage (Equity Multiplier) of J Frontier Co changed from 6.52 to 7.80, representing a 19.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) J Frontier Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s J Frontier Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — J Frontier Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — J Frontier Co